Introduction to FDA 21 CFR Part 11 — Electronic Records and Electronic Signatures

Introduction to FDA 21 CFR Part 11 is a ten-module programme that traces an electronic record from the moment a predicate rule requires it through to its inspection-ready archive — treating every system control as either preserving or breaking the regulation's promise that electronic records are 'trustworthy, reliable, and equivalent to paper'. The course is built around the regulated activities that matter most under FDA scrutiny — manufacturing batch records, laboratory results, clinical eCRFs, document approvals, and cloud-based GxP data — and explains why audit trail review, access control, and computer system validation account for the majority of FDA 483 observations under data integrity. Learners are taken through the predicate-rule test, §11.10 closed-system controls, §11.30 open-system additions, the 2003 narrow-interpretation guidance, audit trails, e-signatures, GAMP 5 / CSA validation, ALCOA+ data integrity, inspection readiness, system-by-system implementation, and the EU GMP Annex 11 / MHRA / PIC/S crosswalk.

Introduction to FDA 21 CFR Part 11 is recommended for manufacturing professionals, quality assurance and regulatory affairs specialists, validation engineers, IT and systems managers, compliance officers, and clinical operations staff — anyone whose hands touch a GxP electronic record between its creation and its retention. The course is well suited to new hires in pharma, biotech, medical device, contract research, and contract manufacturing organisations that operate FDA-regulated electronic systems. On completion, learners are able to apply the three-part predicate-rule test to bring records into or out of Part 11 scope, specify and verify a compliant audit trail under §11.10(e), distinguish closed and open systems, implement two-factor and biometric e-signatures per §11.50/.70/.100/.200/.300, run a risk-based GAMP 5 / CSA validation lifecycle, recognise and remediate common 483 / Warning Letter findings, apply Part 11 thinking to MES / LIMS / EDMS / ERP / Cloud / AI-ML systems, and crosswalk Part 11 to EU GMP Annex 11 and other global regimes. Institutions get a defensible training record aligned to 21 CFR Part 11, FDA 2003 Scope and Application Guidance, FDA 2018 Data Integrity Q&A, FDA 2022 CSA Draft Guidance, MHRA GxP Data Integrity, PIC/S PI 041-1, EU GMP Annex 11, and ICH Q9.